EARNINGS (LOSS) PER SHARE

3 Months Ended

Mar. 31, 2021

LOSS PER SHARE

Basic earnings (loss) per share is computed by dividing the Company’s net income (loss) by the weighted average number of shares outstanding during the period. When the effects are not anti-dilutive, diluted earnings (loss) per share is computed by dividing the Company’s net income (loss) by the weighted average number of shares outstanding and the impact of all dilutive potential common shares, primarily stock options “in-the-money”, unvested restricted stock, and unvested restricted stock units. The dilutive impact of stock options, unvested restricted stock, and unvested restricted stock units is determined by applying the “treasury stock” method. Performance-based restricted stock awards are included in the computation of diluted earnings per share only to the extent that the underlying performance conditions: (i) are satisfied prior to the end of the reporting period; or (ii) would be satisfied if the end of the reporting period were the end of the related performance period and the result would be dilutive under the treasury stock method. Stock awards subject to vesting or exercisability based on the achievement of market conditions are included in the computation of diluted earnings per share only when the market conditions are met.

A reconciliation of the numerators and denominators of the basic and diluted loss per share calculations for the three months ended March 31, 2021 and 2020 were as follows:


	Three Months Ended March 31,
		2021		2020
Loss per share (“EPS”):
EPS - basic and diluted:


Loss per share		$	(0.07)	$	(0.17)




EPS numerator - basic and diluted:


Net loss		$	(203)	$	(511)
EPS denominator (in thousands):
Weighted average common stock outstanding - basic		2,891		3,065
Common stock equivalents: stock options and restricted stock units (a)		—		—
Weighted average number of common stock outstanding - diluted		2,891		3,065

(a)The diluted weighted average number of shares of common stock outstanding did not differ from the basic weighted average number of shares of common stock outstanding because the effects of any potential common stock equivalents (see Note 6 to the Condensed Consolidated Financial Statements for further details on outstanding stock options and unvested restricted stock units) were anti-dilutive and therefore not included in the calculation of the denominator of dilutive earnings per share.

The weighted average number of shares outstanding used in the computation of diluted net income (loss) per share for the three months ended March 31, 2021 and 2020 did not include the effect of the following potentially outstanding shares of common stock because the effect would have been anti-dilutive:


	Three Months Ended March 31,
		2021	2020
Unvested restricted shares of common stock		52,226	—
Unvested restricted stock units		152,737	35,771
Stock options		—	5,000
Total		204,963	40,771